Intercure (INCR) has a profit margin of -13.22%, below the Healthcare sector average of 14.41%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2025
Trailing 12 months ending Dec 2025
The latest profit margin for INCR is -13.22% as of December 2025. That compares with -28.38% in the prior-year period — up 53.4% year over year. That is below the Healthcare sector average of 14.41%. Investors often review this figure alongside Intercure's historical trend and sector peers before judging valuation or financial health.
Over the past year, INCR's profit margin moved from -28.38% to -13.22% — a 53.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Intercure's valuation or profitability profile.
Against Healthcare companies, INCR currently prints -13.22% for profit margin, while the sector average sits near 14.41%. That is roughly 191.7% below the sector mean. Large gaps often invite a closer look at Intercure's growth, margins, and balance sheet.
Profit Margin shows how effectively Intercure converts resources into returns. At -13.22%, INCR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -28.38% in the prior-year period — up 53.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting INCR's profit margin (-13.22%), review year-over-year change from -28.38%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.